The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Potentiation of α7 nicotinic acetylcholine receptors via an allosteric transmembrane site
Open accessAbstract
Positive allosteric modulators of α7 nicotinic acetylcholine receptors (nAChRs) have attracted considerable interest as potential tools for the treatment of neurological and psychiatric disorders such as Alzheimer's disease and schizophrenia. However, despite the potential therapeutic usefulness of these compounds, little is known about their mechanism of action. Here, we have examined two allosteric potentiators of α7 nAChRs (PNU-120596 and LY-2087101). From studies with a series of subunit chimeras, we have identified the transmembrane regions of α7 as being critical in facilitating potentiation of agonist-evoked responses. Furthermore, we have identified five transmembrane amino acids that, when mutated, significantly reduce potentiation of α7 nAChRs. The amino acids we have identified are located within the α-helical transmembrane domains TM1 (S222 and A225), TM2 (M253), and TM4 (F455 and C459). Mutation of either A225 or M253 individually have particularly profound effects, reducing potentiation of EC20 concentrations of acetylcholine to a tenth of the level seen with wild-type α7. Reference to homology models of the α7 nAChR, based on the 4Å structure of the Torpedo nAChR, indicates that the side chains of all five amino acids point toward an intrasubunit cavity located between the four α-helical transmembrane domains. Computer docking simulations predict that the allosteric compounds such as PNU-120596 and LY-2087101 may bind within this intrasubunit cavity, much as neurosteroids and volatile anesthetics are thought to interact with GABA A and glycine receptors. Our findings suggest that this is a conserved modulatory allosteric site within neurotransmitter-gated ion channels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
On the nature of allosteric transitions: A plausible model
Monod, J., Wyman, J., & Changeux, J.-P. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80285-6 · Cited by 8,825
A semiempirical free energy force field with charge‐based desolvation
Huey, R., Morris, G. M., Olson, A. J., & Goodsell, D. S. (2007) · Journal of Computational Chemistry · doi:10.1002/jcc.20634 · Cited by 2,246
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors
Brejc, K., van Dijk, W. J., Klaassen, R. V., Schuurmans, M., van der Oost, J., Smit, A. B., & Sixma, T. K. (2001) · Nature · doi:10.1038/35077011 · Cited by 1,759
Refined Structure of the Nicotinic Acetylcholine Receptor at 4Å Resolution
Unwin, N. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.12.031 · Cited by 1,659
Structure and gating mechanism of the acetylcholine receptor pore
Miyazawa, A., Fujiyoshi, Y., & Unwin, N. (2003) · Nature · doi:10.1038/nature01748 · Cited by 1,270
Sites of alcohol and volatile anaesthetic action on GABAA and glycine receptors
Mihic, S. J., Ye, Q., Wick, M. J., Koltchine, V. V., Krasowski, M. D., Finn, S. E., Mascia, M. P., Valenzuela, C. F., Hanson, K. K., Greenblatt, E. P., et al. (1997) · Nature · doi:10.1038/38738 · Cited by 1,219
Acetylcholine receptor channel imaged in the open state
Unwin, N. (1995) · Nature · doi:10.1038/373037a0 · Cited by 999
Primary Structure And Functional Expression of the 5HT 3 Receptor, A Serotonin-gated Ion Channel
Maricq, A. V., Peterson, A. S., Brake, A. J., Myers, R. M., & Julius, D. (1991) · Science · doi:10.1126/science.1718042 · Cited by 979
Couturier, S., Bertrand, D., Matter, J.-M., Hernandez, M.-C., Bertrand, S., Millar, N., Valera, S., Barkas, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Self-citationEndogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752
Allosteric Mechanisms of Signal Transduction
Changeux, J.-P., & Edelstein, S. J. (2005) · Science · doi:10.1126/science.1108595 · Cited by 747
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Taly, A., Corringer, P.-J., Guedin, D., Lestage, P., & Changeux, J.-P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 703
Jensen, A. A., Frølund, B., Liljefors, T., & Krogsgaard-Larsen, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040219e · Cited by 542
Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor
Revah, F., Bertrand, D., Galzi, J.-L., Devillers-Thiéry, A., Mulle, C., Hussy, N., Bertrand, S., Ballivet, M., & Changeux, J.-P. (1991) · Nature · doi:10.1038/353846a0 · Cited by 525
Evolutionary history of the ligand-gated ion-channel superfamily of receptors
Ortells, M. O., & Lunt, G. G. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93887-4 · Cited by 524
Recent advances in Cys-loop receptor structure and function
Sine, S. M., & Engel, A. G. (2006) · Nature · doi:10.1038/nature04708 · Cited by 521
Hurst, R. S., Hajós, M., Raggenbass, M., Wall, T. M., Higdon, N. R., Lawson, J. A., Rutherford-Root, K. L., Berkenpas, M. B., Hoffmann, W. E., Piotrowski, D. W., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5269-04.2005 · Cited by 446
Diversity of vertebrate nicotinic acetylcholine receptors
Millar, N. S., & Gotti, C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.041 · Cited by 441
Self-citationCys-loop receptors: new twists and turns
LESTER, H. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.002 · Cited by 438
Le Novere, N., & Changeux, J.-P. (1995) · Journal of Molecular Evolution · doi:10.1007/bf00167110 · Cited by 427
Amin, J., & Weiss, D. S. (1993) · Nature · doi:10.1038/366565a0 · Cited by 426
Le Novère, N., Corringer, P., & Changeux, J. (2002) · Journal of Neurobiology · doi:10.1002/neu.10153 · Cited by 411
Dellisanti, C. D., Yao, Y., Stroud, J. C., Wang, Z.-Z., & Chen, L. (2007) · Nature Neuroscience · doi:10.1038/nn1942 · Cited by 407
Chimaeric nicotinic–serotonergic receptor combines distinct ligand binding and channel specificities
Eiselé, J.-L., Bertrand, S., Galzi, J.-L., Devillers-Thiéry, A., Changeux, J.-P., & Bertrand, D. (1993) · Nature · doi:10.1038/366479a0 · Cited by 405
Blind docking of drug‐sized compounds to proteins with up to a thousand residues
Hetényi, C., & van der Spoel, D. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.074 · Cited by 325
Ivermectin: A Positive Allosteric Effector of the α7 Neuronal Nicotinic Acetylcholine Receptor
Krause, R. M., Buisson, B., Bertrand, S., Corringer, P.-J., Galzi, J.-L., Changeux, J.-P., & Bertrand, D. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.2.283 · Cited by 320
Halvard Grønlien, J., Håkerud, M., Ween, H., Thorin-Hagene, K., Briggs, C. A., Gopalakrishnan, M., & Malysz, J. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.035410 · Cited by 271
Ohno, K., Hutchinson, D. O., Milone, M., Brengman, J. M., Bouzat, C., Sine, S. M., & Engel, A. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.758 · Cited by 259
Allosteric modulation of nicotinic acetylcholine receptors
Bertrand, D., & Gopalakrishnan, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.011 · Cited by 255
Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain.
Bertrand, D., Devillers-Thiéry, A., Revah, F., Galzi, J. L., Hussy, N., Mulle, C., Bertrand, S., Ballivet, M., & Changeux, J. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1261 · Cited by 240
Gerzanich, V, Anand, R., & Lindstrom, J. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09916-x · Cited by 217
Timmermann, D. B., Grønlien, J. H., Kohlhaas, K. L., Nielsen, E. Ø., Dam, E., Jørgensen, T. D., Ahring, P. K., Peters, D., Holst, D., Chrsitensen, J. K., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120436 · Cited by 216
Neuronal nicotinic receptors: A perspective on two decades of drug discovery research
Arneric, S. P., Holladay, M., & Williams, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.033 · Cited by 208
Assembly and subunit diversity of nicotinic acetylcholine receptors
Millar, N. S. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310869 · Cited by 208
Self-citationNormal Mode Analysis Suggests a Quaternary Twist Model for the Nicotinic Receptor Gating Mechanism
Taly, A., Delarue, M., Grutter, T., Nilges, M., Le Novère, N., Corringer, P.-J., & Changeux, J.-P. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.050229 · Cited by 189
Schwartz, T. W., & Holst, B. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.008 · Cited by 173
Galzi, J.-L., Bertrand, D., Devillers-Thiéry, A., Revah, F., Bertrand, S., & Changeux, J.-P. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80668-s · Cited by 172
Nootropic α7 nicotinic receptor allosteric modulator derived from GABA A receptor modulators
Ng, H. J., Whittemore, E. R., Tran, M. B., Hogenkamp, D. J., Broide, R. S., Johnstone, T. B., Zheng, L., Stevens, K. E., & Gee, K. W. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701321104 · Cited by 169
Spontaneous openings of the acetylcholine receptor channel.
Jackson, M. B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3901 · Cited by 159
Ye, Q., Koltchine, V. V., Mihic, S. J., Mascia, M. P., Wick, M. J., Finn, S. E., Harrison, N. L., & Harris, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3314 · Cited by 134
Levin, E. D., & Rezvani, A. H. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.019 · Cited by 129
Neuronal nicotinic acetylcholine receptors: from the gene to the disease
Weiland, S., Bertrand, D., & Leonard, S. S. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00199-6 · Cited by 126
Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox
Langmead, C. J., & Christopoulos, A. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.009 · Cited by 117
Hansen, S. B., & Taylor, P. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.067 · Cited by 117
Nicotinic receptors, allosteric proteins and medicine
Changeux, J., & Taly, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.01.001 · Cited by 115
Channel Opening Motion of α7 Nicotinic Acetylcholine Receptor as Suggested by Normal Mode Analysis
Cheng, X., Lu, B., Grant, B. J., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.10.039 · Cited by 109
The nicotinic acetylcholine receptor: From molecular biology to cognition
Changeux, J., Corringer, P., & Maskos, U. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.03.024 · Cited by 101
Taly, A., Corringer, P., Grütter, T., de Carvalho, L. P., Karplus, M., & Changeux, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607477103 · Cited by 99
Iorga, B., Herlem, D., Barré, E., & Guillou, C. (2006) · Journal of Molecular Modeling · doi:10.1007/s00894-005-0057-z · Cited by 97
The multiple phenotypes of allosteric receptor mutants.
Galzi, J., Edelstein, S. J., & Changeux, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1853 · Cited by 96
Broad, L. M., Zwart, R., Pearson, K. H., Lee, M. W., Wallace, L., McPhie, G. I., Emkey, R., Hollinshead, S. P., Dell, C. P., Baker, S., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104505 · Cited by 96
Self-citationAllosteric Modulators of the α7 Nicotinic Acetylcholine Receptor
Faghih, R., Gopalakrishnan, M., & Briggs, C. A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070256g · Cited by 95
Papke, R. L., & Thinschmidt, J. S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00786-1 · Cited by 87
Jensen, A. A., Frølund, B., Liljefors, T., & Krogsgaard‐Larsen, P. (2005) · ChemInform · doi:10.1002/chin.200541286 · Cited by 84
Photoaffinity labeling of Torpedo acetylcholine receptor by physostigmine
Schrattenholz, A. S., Godovac‐Zimmermann, J., Schäfer, H., Albuquerque, E. X., & Maelicke, A. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18187.x · Cited by 80
Methyl lycaconitine: A novel nicotinic antagonist
Drasdo, A. L., Caulfield, M. P., Bertrand, D., Bertrand, S., & Wonnacott, S. (1992) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(92)90043-2 · Cited by 78
Ziebell, M. R., Nirthanan, S., Husain, S. S., Miller, K. W., & Cohen, J. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313886200 · Cited by 77
Kinetic, Mechanistic, and Structural Aspects of Unliganded Gating of Acetylcholine Receptor Channels
Grosman, C. F., & Auerbach, A. L. (2000) · The Journal of General Physiology · doi:10.1085/jgp.115.5.621 · Cited by 73
Paradoxical allosteric effects of competitive inhibitors on neuronal α7 nicotinic receptor mutants
Bertrand, S., Devillers‐Thiéry, A., Palma, E., Buisson, B., Edelstein, S. J., Corringer, P., Changeux, J., & Bertrand, D. (1997) · Neuroreport · doi:10.1097/00001756-199711100-00034 · Cited by 70
Nicotinic Acetylcholine receptors: from molecular biology to cognition
Davenport, A. P. (2006) · British Journal of Neurosurgery · doi:10.1080/02688690600682770 · Cited by 66
Broadbent, S. D., Groot‐Kormelink, P. J., Krashia, P., Harkness, P. C., Millar, N. S., Beato, M., & Sivilotti, L. G. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026682 · Cited by 60
Self-citationJackson, M. B., Imoto, K., Mishina, M., et al. (1990) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00370689 · Cited by 51
Allosteric modifiers of neuronal nicotinic acetylcholine receptors: New methods, new opportunities
Moaddel, R., Jóźwiak, K., & Wainer, I. W. (2007) · Medicinal Research Reviews · doi:10.1002/med.20091 · Cited by 48
Young, G. T., Broad, L. M., Zwart, R., Astles, P. C., Bodkin, M. J., Sher, E., & Millar, N. S. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030809 · Cited by 45
Self-citationHu, M., Gopalakrishnan, M., & Li, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00474.x · Cited by 36
Gee, V. J., Kracun, S., Cooper, S. T., Gibb, A. J., & Millar, N. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707429 · Cited by 33
Self-citationAccessibility to residues in transmembrane segment four of the glycine receptor
Lobo, I. A., Trudell, J. R., & Harris, R. A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.017 · Cited by 30
Liu, Q., Yu, K., Chang, Y., Lukas, R. J., & Wu, J. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00760.x · Cited by 25
Harkness, P. C., & Millar, N. S. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00042-9 · Cited by 14
Self-citation(1998) · doi:10.1002/(sici)1096-987x(19981115)19:14<1639::aid-jcc10>3.0.co;2-b
Cited by
Principles of activation and permeation in an anion-selective Cys-loop receptor
Hibbs, R. E., & Gouaux, E. (2011) · Nature · doi:10.1038/nature10139 · Cited by 995
Crystal structure of a human GABAA receptor
Miller, P. S., & Aricescu, A. R. (2014) · Nature · doi:10.1038/nature13293 · Cited by 710
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Taly, A., Corringer, P.-J., Guedin, D., Lestage, P., & Changeux, J.-P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 703
Structure and gating mechanism of the α7 nicotinic acetylcholine receptor
Noviello, C. M., Gharpure, A., Mukhtasimova, N., Cabuco, R., Baxter, L., Borek, D., Sine, S. M., & Hibbs, R. E. (2021) · Cell · doi:10.1016/j.cell.2021.02.049 · Cited by 299
Binding, activation and modulation of Cys-loop receptors
Miller, P. S., & Smart, T. G. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.12.005 · Cited by 299
Metadata
- Authors
- Young, G. T., Zwart, R., Walker, A. S., Sher, E., & Millar, N. S.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2008-09-23
- Volume
- 105
- Issue
- 38
- Pages
- 14686-14691
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1513702727
- Cited by
- 261
- References
- 70
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.